Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients.
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
Primary objective was to evaluate the efficacy between daily and pulse oral alfacalcidol
treatment of SHPT in chronic hemodialysis patients, a 12-week treatment. Secondary objective
was to observe the adverse effects between these two treatment regimens.